Targeting β-catenin in acute myeloid leukaemia: past, present, and future perspectives
Sign Up to like & getrecommendations! Published in 2022 at "Bioscience Reports"
DOI: 10.1042/bsr20211841
Abstract: Abstract Acute myeloid leukaemia (AML) is an aggressive disease of the bone marrow with a poor prognosis. Evidence suggests long established chemotherapeutic regimens used to treat AML are reaching the limits of their efficacy, necessitating… read more here.
Keywords: catenin acute; leukaemia; targeting catenin; acute myeloid ... See more keywords